China 6-bromo-3-hydroxypyrazine Factory

We've been also focusing on improving upon the stuff management and QC program to make sure that we could hold fantastic gain in the fiercely-competitive enterprise for 6-bromo-3-hydroxypyrazine,CAS NO 259793-88-9,259793-88-9,Favipiravir intermediate,Favipiravir advance intermediate, Honesty is our principle, professional operation is our work, service is our goal, and customers' satisfaction is our future!
6-bromo-3-hydroxypyrazine, Our company always concentrate on the development of the international market. We've got a lot of customers in Russia , European countries, the USA, the Middle East countries and Africa countries. We always follow that quality is foundation while service is guarantee to meet all customers.

Hot Products

  • (S)Ibr09A

    (S)Ibr09A

    Product Name:(S)Ibr09A
    Molecular Formula:C22H23ClN6O
    Molecular Weight:422.92
    CAS Registry Number:2031255-22-6
  • 5-Chlorovaleronitrile

    5-Chlorovaleronitrile

    Product Name:5-Chlorovaleronitrile
    Molecular Formula:C5H8ClN
    Molecular Weight:117.58
    CAS Registry Number:6280-87-1
  • Furosemide

    Furosemide

    Product Name:Furosemide
    Molecular Formula:C12H11ClN2O5S
    Molecular Weight;330.74
    CAS Registry Number;54-31-9
  • (S)-4-N-Boc-2-methylpiperazine

    (S)-4-N-Boc-2-methylpiperazine

    Product Name:(S)-4-N-Boc-2-methylpiperazine
    Molecular Formula:C10H20N2O2
    Molecular Weight:200.28
    CAS Registry Number:147081-29-6
  • Mepivacaine hydrochloride

    Mepivacaine hydrochloride

    Product Name:Mepivacaine hydrochloride
    Molecular Formula:C15H22N2O.ClH
    Molecular Weight;282.81
    CAS Registry Number;1722-62-9
  • Piperacillin sodium salt

    Piperacillin sodium salt

    Product Name:Piperacillin sodium salt
    Molecular Formula:C23H26N5NaO7S
    Molecular Weight;539.54
    CAS Registry Number;59703-84-3

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept